Tag: PAD

JanOne Changes Internal Drug Candidate Name from TV1001SR to JAN101

LAS VEGAS, Aug. 4, 2020 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, announces a internal name change for its current drug candidate from TV1001SR to JAN101, soon to enter Phase 2b clinical trials as a potential treatment Peripheral […]

JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain

Houston Methodist Research Institute Professor and Chair of the Department of Cardiovascular Sciences Dr. John Cooke and LSU Health Shreveport Vice Chancellor Dr. Alan Kaye Join the JanOne Team LAS VEGAS, July 30, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing […]

Zelira Therapeutics Enters Agreement with Cardiovascular Solutions of Central Mississippi to Develop Products

Addressing Health Risks in Patients with Peripheral Arterial Disease and Diabetic Neuropathies PHILADELPHIA, July 22, 2020 /PRNewswire/ — Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the development of clinically validated cannabis medicines, is pleased to announce it has entered into a binding agreement with US-based Cardiovascular Solutions of Central Mississippi to develop products […]

Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease

Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease FDA has agreed to key aspects of the clinical program, including the primary endpoint for the single pivotal phase 3 study There are approximately 175,000 and 150,000 ESKD patients with PAD […]

Modern Vascular Makes Commitment to Reduce Amputations Due to Peripheral Artery Disease (PAD) in Memphis Area

SOUTHAVEN, Miss., July 20, 2020 /PRNewswire/ — Modern Vascular, a pioneering medical group dedicated to preventing amputation through the treatment of peripheral artery disease (PAD) in the lower leg, today announced the expansion of its national footprint with the opening of its newest office in Southaven, MS. Modern Vascular will begin consultations for patients experiencing […]

Modern Vascular Brings New Treatment Options for Peripheral Artery Disease (PAD) to Fort Worth

New Facility Represents Commitment to Reducing Lower Leg Amputations for Area Residents FORT WORTH, Texas, June 29, 2020 /PRNewswire/ — Modern Vascular, a pioneering medical group dedicated to preventing amputation through the treatment of peripheral artery disease (PAD) in the lower leg, today announced the expansion of its national footprint with the opening […]

JanOne taps distinguished chemist Dr. Doug Flanagan as chief formulation advisor

Dr. Flanagan, an accomplished chemist and formulation specialist, leads manufacturing and clinical development of JanOne’s PAD candidate TV1001SR LAS VEGAS, June 25, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, continues to build […]

Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial Multicenter ACTIVATE I Study to Enroll up to 15 Patients in t

SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical Inc. announced that it has enrolled the first two patients in ACTIVATE I, a Phase 1 clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding (NVS) technology. The therapy is designed to open vessels and keep them open without the use […]

AngioSoma’s Development of Atherectomy Catheter

Houston, TX, May 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company’s peripheral arterial disease (“PAD”) product, Atherectomy Catheter II, is a catheter-based platform capable of treating a broad range of plaque types, including calcified plaque and addresses many […]

Modern Vascular Among First Medical Facilities in the Country to Perform Post-Angioplasty Dissection Repair Below The Knee with Newly FDA-Approved Tack Endovascular System®

NORTH MESA, Ariz., April 22, 2020 (GLOBE NEWSWIRE) — Modern Vascular today announced that it was one of the first medical facilities in the country – and currently the only facility in the Western United States — to perform post-angioplasty dissection repair below the knee (BTK) with the Tack® (4F) […]